|Bid||178.15 x 100|
|Ask||179.08 x 100|
|Day's Range||176.52 - 179.20|
|52 Week Range||133.64 - 184.21|
|PE Ratio (TTM)||17.02|
|Dividend & Yield||4.60 (2.59%)|
|1y Target Est||N/A|
A biotech breakout may be fueled by positive medical data and earnings
Vertex (VRTX) got a significant boost with positive data from its cystic fibrosis (CF) pipeline while quite a few companies provided regulatory updates.
Whether the stock market's up or down, Enterprise Product Partners, Automatic Data Processing, and Amgen should keep the dividends flowing.